LEGACY EMANUEL HOSPITAL & HEALTH CTR
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $11.2M
- Transactions
- 1,978
- Companies
- 40
- Average per transaction
- $5,666
Who reported the payments
| Biotronik Inc. | $5,329,942 |
| AbbVie | $1,279,924 |
| Takeda Pharmaceuticals U.S.A., Inc. | $586,787 |
| Heidelberg Engineering, Inc. | $496,332 |
| Novartis | $466,990 |
| Janssen Research & Development, LLC | $372,600 |
| Jazz Pharmaceuticals Inc. | $342,705 |
| Edwards Lifesciences | $303,768 |
| Sanofi | $237,606 |
| Alcon Research LLC | $184,436 |
| Shire North American Group Inc | $167,265 |
| United Therapeutics Corporation | $143,293 |
| Pfizer | $117,275 |
| Insulet Corporation | $102,450 |
| Boston Scientific | $102,123 |
| Abbott | $96,850 |
| Biotronik NRO, Inc. | $87,713 |
| Stryker | $73,295 |
| UCB GmbH | $68,457 |
| E.r. Squibb & Sons, L.L.C. | $62,232 |
| Linde Gas & Equipment Inc. | $60,471 |
| Intuitive Surgical Operations, Inc. | $54,250 |
| KCI USA, Inc. | $47,250 |
| UCB SA | $46,745 |
| Medical Device Business Services, Inc. | $34,574 |
| Ascendis Pharma Endocrinology Inc | $31,627 |
| Astrazeneca UK Limited | $27,220 |
| Tandem Diabetes Care, Inc. | $26,200 |
| Astellas Pharma Global Development | $25,900 |
| Genentech, Inc. | $23,850 |
| Chiesi USA, Inc. | $22,536 |
| Regeneron | $21,686 |
| Mallinckrodt Hospital Products Inc. | $21,600 |
| Actelion Pharmaceuticals, Ltd | $18,850 |
| Davol Inc. | $16,465 |
| Eyepoint US, Inc. | $14,450 |
| Mentor Worldwide LLC | $12,011 |
| Upjohn US 1 LLC | $10,500 |
| Med-el Corporation | $7,950 |
| Gilead | $7,800 |